OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Samuil Umansky

1 Projects | 1 Researchers | $492,000 Invested

2019

DiamiR Biosciences

Samuil Umansky, MD, PhD

Circulating brain-enriched microRNAs as peripheral biomarkers of neurodegeneration.

  • Funding Amount: $492,000
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: Epigenetics
  • Status: Closed